Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

INO Stock Is Caught up in the Coronavirus Gold Rush

By Will Ashworth, InvestorPlace Contributor

Companies like Moderna, Inovio, and Medicago would likely use the victory as bragging rights to develop future vaccines for other super viruses. The development of these things costs significant amounts of money. If you’re the one to crack the coronavirus code in an amazingly rapid amount of time, that will likely translate into billions of future funding, whether debt or equity. 

Starbucks or Luckin Coffee: Is LK Stock the Better Buy?

By Will Ashworth, InvestorPlace Contributor

The simple fact is that Luckin is trading for more than 16 times sales despite losing ground in the past month. Meanwhile, Starbucks is trading for a little more than three times sales. It’s dropped so much the company’s dividend is yielding a respectable 2.4%.

American Airlines Stock Seems Destined for Single Digits

By Will Ashworth, InvestorPlace Contributor

With the markets tumbling into an incredibly volatile state, even the risk-takers may not want to bet on AAL stock

These 7 S&P 500 Stocks Will Deliver a Repeat Performance in the Next Decade

By Will Ashworth, InvestorPlace Contributor

From a list of the 20 best-performing S&P 500 stocks of the past decade, I’ve selected seven that I feel can deliver a repeat performance.  

Inflated CEO Pay Isn’t the Only Problem with Qualcomm Stock

By Will Ashworth, InvestorPlace Contributor

In 2019, Mollenkoft received $23.1 million in total compensation. If you include the stock awards that vested, it was actually $14.9 million higher at $38.0 million. In 2020, he was expected to receive $19.6 million in total compensation. That doesn’t include the one-time awards or the awards that will vest in 2020.

Is Beyond Meat Stock a Buy in the ‘Sixties?’

By Will Ashworth, InvestorPlace Contributor

The volatility stemming from the impact and uncertainty of the coronavirus will likely put a cap on Beyond Meat stock. But once the dark clouds clear, BYND has excellent growth potential.

Consider This One Investment Instead of Buying the Comcast Stock Dip

By Will Ashworth, InvestorPlace Contributor

While Ramer would disagree with this assessment, the general sentiment that Comcast remains a good buy within the telecom and media industries is not a unique one. For every negative due to revenue losses from the coronavirus, analysts argue a business such as Comcast’s may benefit from people staying home and using some of its products and services.

I Doubt You’ll See Warren Buffett Buying IBIO Stock

By Will Ashworth, InvestorPlace Contributor

And, yet, you won’t see Buffett buying iBio despite the fact it’s working on a coronavirus vaccine. You won’t for several primary reasons. 

A 6.2% Yield Makes WFC Stock Attractive, but Its Culture Is Worrisome

By Will Ashworth, InvestorPlace Contributor

At 20, even if an investment in Wells Fargo goes south, a young investor has plenty of time to recover those losses. And, yes, it’s possible that Scharf will be the person to right the ship, recouping a big chunk of Warren Buffett’s recent paper losses.

Pfizer Stock Remains a Cautionary Tale For Investors

By Will Ashworth, InvestorPlace Contributor

Pfizer has seriously underperformed in recent years. Down 10.8% year to date, Pfizer stock remains an underdog.

Load More